Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Clin Exp Dermatol ; 46(4): 795-799, 2021 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-33625737

RESUMO

A 5-year-old boy presented with generalized cutaneous erosions, severe scarring, depigmentation and contractures affecting major joints. The lesions had initially affected his ears, nose, feet, and the genital and ocular mucosa, leading to significant depigmentation, scarring, contractures and mutilation. The whole of the trunk and limbs were involved at the time of presentation, with the exception of some islands of spared skin on the proximal thighs, legs, nipples and external genitalia. Electron microscopy revealed a split in the sublamina densa with the absence of anchoring fibrils, suggestive of dystrophic epidermolysis bullosa (EB). Immunofluorescence antigen mapping demonstrated a broad reticulate pattern of staining with collagen IV, VII, and laminin 332 in the floor of the blister, suggestive of Kindler syndrome. Next-generation sequencing revealed a de novo heterozygous missense mutation (a variant of unknown significance) in exon 22 of the phospholipase-C gamma 2 gene (PLCG2), which resulted in a substitution of serine by asparagine at codon 798 (p.Asp798Ser), a result that was validated using Sanger sequencing. The child was diagnosed with PLCG2-associated antibody deficiency and immune dysregulation (PLAID)/autoinflammation and PLCG2-associated antibody deficiency and immune dysregulation (APLAID) syndrome. The cutaneous and corneal erosions, inflammation and scarring of this magnitude, and the eventual result of death have not been described previously for the PLAID/APLAID spectrum previously. In conclusion, this was an unusual acquired autoinflammatory severe EB-like disease that may be associated with de novo PLCG2 mutation.


Assuntos
Epidermólise Bolhosa/genética , Mutação de Sentido Incorreto , Fosfolipase C gama/genética , Vesícula/genética , Pré-Escolar , Sequenciamento de Nucleotídeos em Larga Escala , Humanos , Masculino , Microscopia Eletrônica , Doenças Periodontais/genética , Fenótipo , Transtornos de Fotossensibilidade/genética , Pele/patologia
2.
Int J Lab Hematol ; 38(5): 520-6, 2016 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-27339613

RESUMO

INTRODUCTION: Laboratory diagnosis of hereditary spherocytosis (HS) relies on increased incubated red cell osmotic fragility test for screening. We evaluated the diagnostic role of eosin-5'-maleimide (EMA) binding test by flow cytometry in spherocytic and microcytic hypochromic hematological disorders in North Indians. METHODS: EMA binding test using flow cytometry was performed on 55 HS (40 families), 26 iron deficiency anemia (IDA), 32 ß-thalassemia trait (ßTT), and 10 autoimmune hemolytic anemia (AIHA) cases and 121 normals. Mean channel fluorescence (MCF) and coefficient of variation (CV) were studied. Different MCF parameters (MCF, MCF ratio, percent decrease MCF) and percent increase in CV were analyzed. Receiver operating characteristics analysis was performed to determine best cutoff values, sensitivity, and specificity for discriminating HS from other red cell disorders. RESULTS: MCF ratio of HS group was significantly lower than normals (0.67 ± 0.07 vs. 1.01 ± 0.05, P < 0.001) and other cases. All patients with HS showed MCF ratio to be ≤0.79. Four postsplenectomy cases with near-normal hemograms also revealed low MCF ratio, showing the specificity of the test. CONCLUSIONS: EMA assay was efficient to diagnose cases of HS including postsplenectomy cases and shows no overlap with IDA, ßTT, and AIHA.


Assuntos
Amarelo de Eosina-(YS)/análogos & derivados , Citometria de Fluxo/métodos , Esferocitose Hereditária/sangue , Esferocitose Hereditária/diagnóstico , Adolescente , Adulto , Anemia Ferropriva/sangue , Anemia Ferropriva/diagnóstico , Criança , Pré-Escolar , Amarelo de Eosina-(YS)/farmacologia , Feminino , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Talassemia beta/sangue , Talassemia beta/diagnóstico
3.
J Anim Physiol Anim Nutr (Berl) ; 97(2): 315-21, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22289079

RESUMO

To study the effect of vitamin E (VE), copper (Cu) and zinc (Zn) supplementation on the in vitro phagocytic activity (PA) and lymphocyte proliferation response (LPR) of blood neutrophils and lymphocytes, thirty Sahiwal pregnant cows (six in each group) in their late gestation at 30 days before the expected date of calving were selected from the NDRI experimental herd and supplemented with various micronutrients from 30 days before calving to 45 days after calving. Cows were supplemented individually with VE (1000 IU/cow/day), Cu (20 ppm/cow/day) and Zn (80 ppm/cow/day) and also with a combination of VE, Cu and Zn to study cumulative effect of all micronutrients. One group without any supplementation acted as a control. Blood neutrophils and lymphocytes were isolated and studied for their PA and LPR. Supplementation of micronutrients like VE, Cu, Zn and a combination of all these nutrients significantly (p < 0.01) increased the PA of experimental cows as compared to control (unsupplemented) cows during the pre-partum period. During post-partum, all the micronutrients (VE, Cu, Zn and their combination) showed a significant (p < 0.01) increase in the PA of experimental cows as compared to control cows. Of all the groups, significant (p < 0.01) and maximum PA was observed in the combination group followed by Zn-supplemented group during both the pre- and post-partum period. A significant (p < 0.01) increase in LPR of B lymphocytes was observed in combination-supplemented group during the pre-partum period and during both the pre- and post-partum period in the Cu-supplemented group.


Assuntos
Bovinos/fisiologia , Cobre/farmacologia , Linfócitos/efeitos dos fármacos , Fagocitose/efeitos dos fármacos , Vitamina E/farmacologia , Zinco/farmacologia , Ração Animal , Fenômenos Fisiológicos da Nutrição Animal , Animais , Proliferação de Células/efeitos dos fármacos , Cobre/administração & dosagem , Dieta/veterinária , Suplementos Nutricionais , Esquema de Medicação , Feminino , Linfócitos/fisiologia , Período Periparto , Gravidez , Vitamina E/administração & dosagem , Zinco/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA